Literature DB >> 9088940

A biochemical and immuno-electron microscopical analysis of chondroitin sulphate-rich proteoglycans in human alveolar bone.

A J Smith1, S K Singhrao, G R Newman, R J Waddington, G Embery.   

Abstract

This study used biochemical and immunohistochemical methods to characterize the chondroitin sulphate-rich proteoglycans from human alveolar bone obtained from an oral source. Proteoglycans were extracted from bone by a sequential 4 M guanidine HCl extraction process, and purified by DEAE-ion exchange chromatography. SDS-PAGE and Western blot analysis, using CS-56 monoclonal antibody, demonstrated one major proteoglycan species with a core protein of 58 kDa, glycosaminoglycan chains of 45-66 kDa and a mean molecular weight of 205 kDa. This work confirmed the biochemistry of chondroitin sulphate-rich proteoglycans from a novel source of adult human alveolar bone, and pointed towards a proteoglycan with a high glutamate, glycine, aspartate, alanine, serine and leucine content. Sections of alveolar bone were embedded in LR White resin, labelled with CS-56 antibody and examined with the light and electron microscopes. At the light microscope level, labelling was restricted to the osteocyte lacunae and canaliculi. Ultrastructural observations showed that the labelling was localized to fine filamentous material in the walls of the osteocytes and canaliculi. Sparse labelling was associated with the collagen fibres immediately subjacent to the lamina limitans, but no labelling of the mineralized matrix was observed. These findings also indicated subtle differences in the distribution of chondroitin sulphate compared with previously reported work, which may indicate species or age differences in the samples used in this study. Ultrastructural analysis confirmed and extended observations of glycosaminoglycan localization at the osteocyte cell membrane of mature human alveolar bone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088940     DOI: 10.1023/a:1026406932452

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  7 in total

Review 1.  Vibrational spectroscopic techniques to assess bone quality.

Authors:  E P Paschalis; S Gamsjaeger; K Klaushofer
Journal:  Osteoporos Int       Date:  2017-04-05       Impact factor: 4.507

Review 2.  The Cementocyte-An Osteocyte Relative?

Authors:  N Zhao; B L Foster; L F Bonewald
Journal:  J Dent Res       Date:  2016-03-30       Impact factor: 6.116

3.  MUC1 and MUC2 mucins in flat and polypoid colorectal adenomas.

Authors:  Y Ajioka; H Watanabe; J R Jass
Journal:  J Clin Pathol       Date:  1997-05       Impact factor: 3.411

4.  Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy.

Authors:  B Hofstetter; S Gamsjaeger; F Varga; H Dobnig; J J Stepan; H Petto; I Pavo; K Klaushofer; E P Paschalis
Journal:  Osteoporos Int       Date:  2014-07-19       Impact factor: 4.507

Review 5.  Vibrational spectroscopic imaging for the evaluation of matrix and mineral chemistry.

Authors:  S Gamsjaeger; R Mendelsohn; A L Boskey; S Gourion-Arsiquaud; K Klaushofer; E P Paschalis
Journal:  Curr Osteoporos Rep       Date:  2014-12       Impact factor: 5.096

6.  Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone.

Authors:  William R Thompson; Shannon Modla; Brian J Grindel; Kirk J Czymmek; Catherine B Kirn-Safran; Liyun Wang; Randall L Duncan; Mary C Farach-Carson
Journal:  J Bone Miner Res       Date:  2011-03       Impact factor: 6.741

7.  Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis.

Authors:  R Tsukifuji; K Tagawa; A Hatamochi; H Shinkai
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.